Combination of radiosensitizers and hyperthermia in tumour radiotherapy

dc.contributor.author	Brueckner, V.
dc.date.accessioned	2011-03-18T14:59:49Z
dc.date.available	2011-03-18T14:59:49Z
dc.date.issued	1981
dc.description	Review
dc.description.abstract	Specific metabolic properties of hypoxic (and therefore radio-resistant) tumour cells are responsible for the selective effect of radiosensitizers (such as misonidazole) and hyperthermia upon these cells in respect of radiosensitization as well as cytotoxicity. Radiosensitizers and hyperthermia should therefore be used to improve the results of tumour radiotherapy; enhancement ratios of 2-4 have already been attained experimentally with this combined treatment. In spite of these good results, certain problems exist, and up to now the combination of radiosensitizers and hyperthermia has not been used to any great extent for tumours in humans.	en_ZA
dc.format.extent	p. 116-118
dc.identifier.uri	http://hdl.handle.net/10019.1/8078
dc.subject	Cander -- Thermotherapy	en_ZA
dc.subject	Cancer -- Radiotherapy	en_ZA
dc.subject	Radiation-sensitizing agents	en_ZA
dc.title	Combination of radiosensitizers and hyperthermia in tumour radiotherapy	en_ZA
dc.type	Review

Now showing 1 - 1 of 1